GCT President, Dr. Apter at ECNP congress

GCT President, Dr. Jeffrey Apter attended the 32nd ECNP Congress, which took place in Copenhagen, September 7-10. It brought together neuroscientists, psychiatrists and neurologists from all over the world providing them with an opportunity to connect. Various topics of brain research were discussed at the conference including the progress in treatment development for brain disorders.  This was a fruitful and delightful event and a great space to share knowledge and expertise.


Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2021 Global Clinical Trials, LLC

All rights reserved.